Investigational Site Number : 6200002
Braga 4710-243
0 studies enrolling now · 2 studies all time
What they study most
Chronic Obstructive Pulmonary Disease, Plasma Cell Myeloma
Studies at this site
- A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant — Running, not enrolling
- Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed